Entourage Health Corp.
(
TSX-V:ENTG) (
OTCQX:ETRGF)
(
FSE:4WE) (“
Entourage” or the
“
Company”), a Canadian producer and distributor of
award-winning cannabis products and
The Boston Beer
Company, Inc. (NYSE: SAM),
(“BBC”) maker
of iconic, high-quality brands such as Samuel Adams, Truly Hard
Seltzer and Twisted Tea, are pleased to announce the Canadian debut
of ‘TeaPot’, a new line of cannabis-infused iced tea beverages.
Developed and formulated alongside Boston Beer’s cannabis
subsidiary BBCCC Inc., and Windsor-based
Peak Processing
Solutions (“Peak”), TeaPot is BBC’s first infused beverage
offering which will be available in select Canadian provinces
commencing July 2022.
TeaPot blends real tea with unique cannabis
cultivars to give each TeaPot blend a pairing that is cleverly
named to correlate with specific times of the day. The brand’s
first release is a ‘Good Day Iced Tea’, made with real-lemon black
tea and infused with Pedro's Sweet Sativa, a distinguished cultivar
grown and sold exclusively by Entourage under its Color Cannabis
retail brand. Each 12-ounce (355ml) can of TeaPot contains 5mg of
THC and is crafted to minimize any cannabis taste or aroma. TeaPot
will introduce additional varietals in the coming months.
“We congratulate our partners at The Boston Beer
Company on the exciting launch of TeaPot - a unique iced tea
crafted with natural flavours and infused with our most
distinguished cultivars that we expect will land as the best
cannabis-infused beverages in Canada,” said George Scorsis, CEO and
Executive Chairman, Entourage. “The BBC team has a storied history
and pedigree for producing some of the most beloved craft beverages
in North America and we’re thrilled to be introducing yet another
consumption method for the canna-curious consumer and growing
self-care market. Together, our consumer-savvy, quality-driven
approach to product development has made for a complementary
collaboration alongside Peak, our processing and bottling partner,
ensuring every beverage is prepared with the highest care and
excellence. TeaPot will be an instant hit this summer as it debuts
in select provinces starting in July, with eventual nationwide
distribution expected throughout the year.”
Since 2020, Canada's cannabis-infused beverage
market share has increased by nearly 850%(1), and is approximately
twice the size of the U.S. cannabis beverage market, according to a
recent report from Headset retail data (March 2022). BBC with its
branding and craft beverage expertise; Peak with its robust
manufacturing and processing experience; and Entourage with its
strong Canadian marketing-sales distribution network are together
establishing a partnership that is well-suited to capture a
significant portion of this addressable cannabis-beverage
market.
In 2021, BBC, Peak and Entourage entered into
development, supply, manufacturing, marketing and sale agreements
to develop cannabis-infused beverages using Entourage’s
cannabinoid-rich input biomass cultivated at its
centre-of-excellence in Strathroy-Ontario. The biomass is processed
and formulated into beverages at Peak’s state-of-the-art Windsor,
Ontario facility. Entourage is also the exclusive distributor of
the cannabis-infused beverages in Canada leveraging its expansive
local sales and marketing network on behalf of BBC.
For more information about the TeaPot, visit
http://www.drinkteapot.com/ and follow @DrinkTeaPot on Instagram
and Twitter to receive the latest updates.
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.)
and CannTx Life Sciences Inc., licence holders producing and
distributing cannabis products for both the medical and adult-use
markets. The Company owns and operates a state-of-the-art hybrid
greenhouse and processing facility located on 158-acres in
Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON
processing facility, specializing in cannabis extraction; and a
micropropagation, tissue culture and genetics centre-of-excellence
in Guelph, Ontario. With its Starseed Medicinal medical-centric
brand, Entourage has expanded its multi-channeled distribution
strategy. Starseed’s industry-first, exclusive partnership with
LiUNA, the largest construction union in Canada, along with
employers and union groups complements Entourage’s direct sales to
medical patients. Entourage’s elite adult-use product portfolio
includes Color Cannabis, Saturday Cannabis and Royal City Cannabis
Co. – sold across eight provincial distribution agencies. The
Company also maintains strategic relationships in the seniors’
market and supply agreements with Shoppers Drug Mart. It is the
exclusive Canadian producer and distributor of award-winning
U.S.-based wellness brand Mary’s Medicinals sold in both medical
and adult-use channels. Under a collaboration with The Boston Beer
Company subsidiary, Entourage is also the exclusive distributor of
cannabis-infused beverages in Canada, expected to launch in
2022.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on LinkedIn
Twitter: Entourage, Color Cannabis, Saturday
Cannabis, Starseed & Royal City Cannabis Co.
Instagram: Entourage, Color
Cannabis, Saturday Cannabis, Starseed & Royal City
Cannabis Co.
For further information, please
contact:
For Investor Enquiries:Valter
Pinto or Scott EcksteinKCSA Strategic
Communications1-212-896-1254entourage@kcsa.com investor@entouragecorp.com
For Media Enquiries:Marianella
delaBarreraSVP, Communications & Corporate
Affairs416-897-6644marianella@entouragecorp.com
(1) Headset Report, March 9,
2022 – “Cannabis Beverages: A Look at Category Trends &
Performance”
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy. Forward-looking information included in this press
release includes, but is not limited to, statements in respect of
the Company’s anticipated distribution of its cannabis-infused
beverages in Canada.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/408ecb90-38f1-4bd1-8ac7-f2ccf6d71b7b
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024